Drug Development

BREAST CANCER 1 Credit CME An Overview of Clinical Development of Agents for Metastatic or Advanced Breast Cancer Without ERBB2 Amplification (HER2-Low) JAMA Oncology

BREAST CANCER 1 Credit CME Surrogacy of Pathologic Complete Response in Trials of Neoadjuvant Therapy for Early Breast Cancer: Critical Analysis of Strengths, Weaknesses, and Misinterpretations JAMA Oncology

DIABETES AND ENDOCRINOLOGY 15m 31s Prescription Drug Cost Provisions of the Inflation Reduction Act JAMA

HEALTH POLICY 1 Credit CME Funding Sources of Therapeutic and Vaccine Clinical Trials for COVID-19 vs Non–COVID-19 Indications, 2020-2021 JAMA Network Open

GLOBAL HEALTH 1 Credit CME Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials JAMA Network Open

CLINICAL PHARMACY AND PHARMACOLOGY 1 Credit CME Association of Antineoplastic Therapy With Decreased SARS-CoV-2 Infection Rates in Patients With Cancer JAMA Oncology

LAW AND MEDICINE 21m 13s Medicaid Use and Spending for Drugs With FDA Accelerated Approval JAMA Health Forum

CRITICAL CARE MEDICINE 38m 26s 0.75 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

CRITICAL CARE MEDICINE 47m 41s 0.75 Credit CME Coronavirus Update With Peter Piot, MD, PhD JAMA

SUBSTANCE USE AND ADDICTION MEDICINE 21m 26s Coronavirus Update With CDC Director Rochelle Walensky JAMA

SUBSTANCE USE AND ADDICTION MEDICINE 24m 59s 0.5 Credit CME Coronavirus Update With CDC Director Rochelle Walensky, MD JAMA

HEALTH POLICY 1 Credit CME US Food and Drug Administration Support for Oncology Drug Development During COVID-19 JAMA Oncology

CORONAVIRUS (COVID-19) 1 Credit CME The Challenges Ahead With Monoclonal Antibodies: From Authorization to Access JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Therapy for Early COVID-19: A Critical Need JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Study Aims to Identify Drugs That Could Be Repurposed for COVID-19 JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 31m 28s 0.5 Credit CME Ten Things Every New Doctor Should Know About Drug Reactions JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies JAMA Internal Medicine

CLINICAL PHARMACY AND PHARMACOLOGY 12m 50s 0.25 Credit CME Update on Dexamethasone for the Treatment of COVID-19 JAMA

CORONAVIRUS (COVID-19) 1 Credit CME Missed Opportunities on Emergency Remdesivir Use JAMA

CLINICAL PHARMACY AND PHARMACOLOGY 36m 28s 0.5 Credit CME Remdesivir and Dexamethasone for the Treatment of COVID-19 JAMA